GAITHERSBURG, MD, Vector BioMed, a biomanufacturing company specializing in the manufacture of lentiviral vectors, announced its launch and first financing round.
NEW YORK, NY, TBD Health, a sexual healthcare provider revolutionizing the medical landscape through unparalleled digital and in-person clinical care, today announced a $4.4 million seed round.
Embedded is led by general partners Jenna Bryant and Jordan Noone, the latter who came to the VC side after co-founding 3D rocket printer Relativity Space.
LOS ANGELES, CA, Spatial Labs, the leading infrastructure company powering new technologies to redefine the consumer experience for the next generation, announced today a $10 million seed funding round.
NEW YORK, NY, Elaborate, the tool that doctors and their staff use to deliver contextualized, action-oriented lab results to patients, has raised $10 million in Seed funding.
LEXINGTON, MA, iVexSol, a technology-based lentiviral vector contract development and manufacturing organization, announced $23.8 million in Series A-3 funding.
NEW YORK, NY, Precision Neuroscience, a brain-computer interface company, announced a $41 million Series B funding round led by Forepont Capital Partners.
AUSTIN, TX, RapidDeploy, a provider of cloud-native 911 mapping and analytics solutions, announced $34 million in new growth capital led by Edison Partners.
For founders to most effectively bridge the valuation gap between themselves and investors, they must establish trust through the following four approaches.
The Silicon Valley startup economy has been decimated by rising interest rates and the market downturn, but some of the best tech has been born of recession.
David Sambur, Apollo Partner and co-head of private equity, joins 'The Exchange' to discuss debt in corporate America, investment strategies for constrained financing methods, and the delays associated with today's FAA...
CNBC is now accepting nominations for the 2023 Disruptor 50 list, our annual look at innovative companies using breakthrough tech to meet increasing challenges.
As the IPO market remains frozen, one tech analyst is optimistic that we could see a rebound in public listings as early as the second half of this year.